Comments on: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China

Comments on: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China https://www.theinfostride.com/triple-agonist-ubt251-delivers-up-to-19-7-mean-weight-loss-after-24-weeks-in-phase-2-trial-in-china/ Breaking News, Nigeria News and Top Stories Tue, 24 Feb 2026 09:00:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4